Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine

Androgen deprivation therapy (ADT) has been widely prescribed for patients with advanced prostate cancer (PC) to control key signaling pathways via androgen receptor (AR) and AR-collaborative transcriptional factors; however, PC gradually acquires a lethal phenotype and results in castration-resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimura, Tetsuya, Takayama, Kenichi, Takahashi, Satoru, Inoue, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836061/
https://www.ncbi.nlm.nih.gov/pubmed/29360794
http://dx.doi.org/10.3390/cancers10020029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836061/
https://www.ncbi.nlm.nih.gov/pubmed/29360794
http://dx.doi.org/10.3390/cancers10020029

Ejemplares similares